Hussman Strategic Advisors, Inc. Novo Cure LTD Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 105,000 shares of NVCR stock, worth $1.86 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
105,000Holding current value
$1.86 Million% of portfolio
0.49%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
294Shares Held
76MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$215 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$209 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$158 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$85.5 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$48.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.86B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...